Détail de l'auteur
Documents disponibles écrits par cet auteur
trié(s) par (Pertinence décroissant(e), Titre croissant(e)) Affiner la rechercheArticle
A. Beddok ; B. Porte ; P. Cottu ; A. Fourquet ; Y. Kirova |Plusieurs études cliniques ont montré que les inhibiteurs de kinase dépendante des cyclines 4/6 (CDK4/6i) permettaient d’allonger la survie des patientes atteintes d’un cancer du sein surexprimant les récepteurs hormonaux et ne surexprimant pas [...]Article
S. Allali ; V. Servois ; A. Beddok ; A. Fourquet ; Y. Kirova |Purpose The coronavirus disease 2019 (covid-19) caused by the severe acute respiratory syndrome coronavirus 2 (Sars-Cov-2) is at the origin of a global pandemic. This pandemic has prompted the current health system to reorganize and rethink the [...]Article
K. Quintin ; P. Loap ; A. Fourquet ; Y. Kirova |Purpose: Helical tomotherapy (HT) is a rotational intensity-modulated radiation therapy (IMRT) technique that allows target conformal irradiation and efficient organs at risk (OAR) sparing in the case of complex target volumes and specific anato[...]Article
Z. Zolcsak ; P. Loap ; A. Fourquet ; Y.M. Kirova |Purpose Intensity-modulated radiotherapy with helical Tomotherapy is a novel radiation therapy technique, which may be beneficial in several features compared to traditional methods. Our aim was to evaluate the local control, overall survival, p[...]Article
F. Courtinat ; P. Cottu ; J.-G. Féron ; N. Jehanno ; A. Fourquet ; Y. Kirova ; A. Beddok |Breast cancer is a frequent and sometimes fatal disease. The risk of locoregional recurrence has considerably decreased since the introduction of adjuvant treatments (radiotherapy, chemotherapy, hormone therapy). Nevertheless, some patients pres[...]Article
C. Hennequin ; Y. Belkacémi ; C. Bourgier ; D. Cowen ; B. Cutuli ; A. Fourquet ; Jean-Michel Hannoun-Lévi ; David Pasquier ; S. Racadot ; S. Rivera |Summary Adjuvant radiotherapy is an essential component of the treatment of breast cancer. After conservative surgery for an infiltrating carcinoma, radiotherapy must be systematically performed, regardless of the characteristics of the disease,[...]Article
M. Michalet ; C. Dejean ; U. Schick ; C. Durdux ; A. Fourquet ; Y. Kirova |We present the updated recommendations of the French society for radiation oncology on radiotherapy and pregnancy. The occurrence of cancer during pregnancy is a rare event (approximately 1 in 1000 pregnancies). The risks for the embryo or the f[...]Article
I. Chaffai ; K. Cao ; M. Kissel ; R. El Ayachy ; A. Aboudaram ; A. Fourquet ; Y. Kirova |Objectif de l’étude La radiothérapie hypofractionnée modérée est devenue une pratique de routine pour une population sélectionnée de patientes traitées pour un cancer du sein de stade précoce. En avril 2020 est publiée l’étude Fast Forward qui [...]Article
S. Allali ; F. Chasset ; Y. Kirova ; C. Saint-Martin ; P. Moguelet ; A. Fourquet ; A. Beddok |Data on the incidence and severity of radiation-induced toxicity in patients with systemic and/or cutaneous lupus erythematosus (SLE/CLE) are very limited. After reporting the case of a patient who experienced major toxicity and CLE flare in the[...]
